Sameer SHARMA
4Patents
2h-index
5Co-inventors
33Inventor score
Filing activity: Nov 24, 2015 → Nov 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11786508B2 | Use of sublingual dexmedetomidine for the treatment of agitation | Human Necessities | 4 | Active |
| US11839604B2 | Use of sublingual dexmedetomidine for the treatment of agitation | Human Necessities | 2 | Active |
| US10610563B2 | Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2 | Physics | 0 | Active |
| US11931340B2 | Use of sublingual dexmedetomidine for the treatment of agitation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.